Seach Medical Group Ltd (TLV: SEMG)
Israel
· Delayed Price · Currency is ILS · Price in ILA206.80
+5.20 (2.58%)
Oct 14, 2024, 5:24 PM IDT
Seach Medical Group Income Statement
Financials in millions ILS. Fiscal year is January - December.
Millions ILS. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '24 Mar 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2016 |
| Revenue | 155.16 | 150.32 | 134.21 | 67.34 | 36.8 | 28.83 | Upgrade
|
| Revenue Growth (YoY) | 10.62% | 12.01% | 99.30% | 82.98% | 27.63% | 55.45% | Upgrade
|
| Cost of Revenue | 119.22 | 112.93 | 95.91 | 44.34 | 19.86 | 15.09 | Upgrade
|
| Gross Profit | 35.94 | 37.4 | 38.3 | 23 | 16.94 | 13.74 | Upgrade
|
| Selling, General & Admin | 37.1 | 38.23 | 32.74 | 16.16 | 10.57 | 7.32 | Upgrade
|
| Research & Development | 1.72 | 1.76 | 1.45 | 2.31 | 1.93 | 1.81 | Upgrade
|
| Other Operating Expenses | 0.28 | -0.23 | 0.08 | 0.12 | -0.24 | -0.05 | Upgrade
|
| Operating Expenses | 39.1 | 39.76 | 34.27 | 18.59 | 12.25 | 9.07 | Upgrade
|
| Operating Income | -3.16 | -2.37 | 4.03 | 4.41 | 4.69 | 4.67 | Upgrade
|
| Interest Expense | -1.46 | -1.81 | -0.94 | -0.17 | -0.09 | -0.32 | Upgrade
|
| Interest & Investment Income | 0.31 | 0.25 | 0.01 | 0.25 | 0.41 | 0.01 | Upgrade
|
| Earnings From Equity Investments | -0.35 | 0.19 | -1.24 | -1 | -1.55 | -0.78 | Upgrade
|
| Other Non Operating Income (Expenses) | -0.88 | -0.88 | -0.73 | -0.25 | -0.61 | -0.15 | Upgrade
|
| EBT Excluding Unusual Items | -5.53 | -4.61 | 1.14 | 3.24 | 2.83 | 3.43 | Upgrade
|
| Impairment of Goodwill | -5.76 | -5.76 | - | - | - | - | Upgrade
|
| Gain (Loss) on Sale of Investments | -1.92 | -2.03 | -5.04 | 0.49 | 6.12 | 3.96 | Upgrade
|
| Gain (Loss) on Sale of Assets | -0.32 | -0.32 | -0.17 | 0.01 | - | -0.02 | Upgrade
|
| Other Unusual Items | 2.44 | 2.44 | 0 | 2.49 | 4.35 | -28.36 | Upgrade
|
| Pretax Income | -11.09 | -10.28 | -4.07 | 6.23 | 13.3 | -20.99 | Upgrade
|
| Income Tax Expense | 1.33 | 1.59 | 1.2 | 1.01 | 1.33 | 1.57 | Upgrade
|
| Earnings From Continuing Operations | -12.42 | -11.87 | -5.27 | 5.23 | 11.97 | -22.55 | Upgrade
|
| Minority Interest in Earnings | 0.56 | 1.36 | 1.86 | 0.12 | - | - | Upgrade
|
| Net Income | -11.86 | -10.51 | -3.41 | 5.35 | 11.97 | -22.55 | Upgrade
|
| Net Income to Common | -11.86 | -10.51 | -3.41 | 5.35 | 11.97 | -22.55 | Upgrade
|
| Net Income Growth | - | - | - | -55.30% | - | - | Upgrade
|
| Shares Outstanding (Basic) | - | 34 | 34 | 34 | 33 | 26 | Upgrade
|
| Shares Outstanding (Diluted) | - | 34 | 34 | 34 | 33 | 26 | Upgrade
|
| Shares Change (YoY) | - | - | 0.79% | 3.61% | 23.40% | 15.00% | Upgrade
|
| EPS (Basic) | - | -0.31 | -0.10 | 0.16 | 0.37 | -0.85 | Upgrade
|
| EPS (Diluted) | - | -0.31 | -0.10 | 0.16 | 0.37 | -0.85 | Upgrade
|
| EPS Growth | - | - | - | -56.86% | - | - | Upgrade
|
| Free Cash Flow | -0.18 | -0.67 | 16.16 | -10.02 | -10.23 | -2.44 | Upgrade
|
| Free Cash Flow Per Share | - | -0.02 | 0.47 | -0.30 | -0.31 | -0.09 | Upgrade
|
| Gross Margin | 23.16% | 24.88% | 28.54% | 34.16% | 46.04% | 47.67% | Upgrade
|
| Operating Margin | -2.04% | -1.57% | 3.00% | 6.55% | 12.74% | 16.20% | Upgrade
|
| Profit Margin | -7.64% | -6.99% | -2.54% | 7.94% | 32.52% | -78.22% | Upgrade
|
| Free Cash Flow Margin | -0.11% | -0.44% | 12.04% | -14.88% | -27.80% | -8.46% | Upgrade
|
| EBITDA | -0.2 | 1.29 | 9.28 | 7.39 | 6.16 | 5.41 | Upgrade
|
| EBITDA Margin | -0.13% | 0.86% | 6.92% | 10.97% | 16.74% | 18.78% | Upgrade
|
| D&A For EBITDA | 2.96 | 3.66 | 5.25 | 2.98 | 1.47 | 0.74 | Upgrade
|
| EBIT | -3.16 | -2.37 | 4.03 | 4.41 | 4.69 | 4.67 | Upgrade
|
| EBIT Margin | -2.04% | -1.57% | 3.00% | 6.55% | 12.74% | 16.20% | Upgrade
|
| Effective Tax Rate | - | - | - | 16.14% | 10.02% | - | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.